Abstract:Machine learning (ML) has transformed neuroimaging research by enabling accurate predictions and feature extraction from large datasets. In this study, we investigate the application of six ML algorithms (Lasso, relevance vector regression, support vector regression, extreme gradient boosting, category boost, and multilayer perceptron) to predict brain age for middle-aged and older adults, which is a crucial area of research in neuroimaging. Despite the plethora of proposed ML models, there is no clear consens… Show more
“…Lasso is widely employed in predictive modeling, particularly when dealing with high-dimensional datasets. Prior investigations into brain-age prediction [35,36] have consistently demonstrated the superior performance of the Lasso model when compared to other machine-learning models. Given these compelling findings, we have chosen the Lasso model as the method of choice for brain-age prediction in our study.…”
Accelerated brain aging (ABA) intricately links with age-associated neurodegenerative and neuropsychiatric diseases, emphasizing the critical need for a nuanced exploration of heterogeneous ABA patterns. This investigation leveraged data from the UK Biobank (UKB) for a comprehensive analysis, utilizing structural magnetic resonance imaging (sMRI), diffusion magnetic resonance imaging (dMRI), and resting-state functional magnetic resonance imaging (rsfMRI) from 31,621 participants. Pre-processing employed tools from the FMRIB Software Library (FSL, version 5.0.10), FreeSurfer, DTIFIT, and MELODIC, seamlessly integrated into the UKB imaging processing pipeline. The Lasso algorithm was employed for brain-age prediction, utilizing derived phenotypes obtained from brain imaging data. Subpopulations of accelerated brain aging (ABA) and resilient brain aging (RBA) were delineated based on the error between actual age and predicted brain age. The ABA subgroup comprised 1949 subjects (experimental group), while the RBA subgroup comprised 3203 subjects (control group). Semi-supervised heterogeneity through discriminant analysis (HYDRA) refined and characterized the ABA subgroups based on distinctive neuroimaging features. HYDRA systematically stratified ABA subjects into three subtypes: SubGroup 2 exhibited extensive gray-matter atrophy, distinctive white-matter patterns, and unique connectivity features, displaying lower cognitive performance; SubGroup 3 demonstrated minimal atrophy, superior cognitive performance, and higher physical activity; and SubGroup 1 occupied an intermediate position. This investigation underscores pronounced structural and functional heterogeneity in ABA, revealing three subtypes and paving the way for personalized neuroprotective treatments for age-related neurological, neuropsychiatric, and neurodegenerative diseases.
“…Lasso is widely employed in predictive modeling, particularly when dealing with high-dimensional datasets. Prior investigations into brain-age prediction [35,36] have consistently demonstrated the superior performance of the Lasso model when compared to other machine-learning models. Given these compelling findings, we have chosen the Lasso model as the method of choice for brain-age prediction in our study.…”
Accelerated brain aging (ABA) intricately links with age-associated neurodegenerative and neuropsychiatric diseases, emphasizing the critical need for a nuanced exploration of heterogeneous ABA patterns. This investigation leveraged data from the UK Biobank (UKB) for a comprehensive analysis, utilizing structural magnetic resonance imaging (sMRI), diffusion magnetic resonance imaging (dMRI), and resting-state functional magnetic resonance imaging (rsfMRI) from 31,621 participants. Pre-processing employed tools from the FMRIB Software Library (FSL, version 5.0.10), FreeSurfer, DTIFIT, and MELODIC, seamlessly integrated into the UKB imaging processing pipeline. The Lasso algorithm was employed for brain-age prediction, utilizing derived phenotypes obtained from brain imaging data. Subpopulations of accelerated brain aging (ABA) and resilient brain aging (RBA) were delineated based on the error between actual age and predicted brain age. The ABA subgroup comprised 1949 subjects (experimental group), while the RBA subgroup comprised 3203 subjects (control group). Semi-supervised heterogeneity through discriminant analysis (HYDRA) refined and characterized the ABA subgroups based on distinctive neuroimaging features. HYDRA systematically stratified ABA subjects into three subtypes: SubGroup 2 exhibited extensive gray-matter atrophy, distinctive white-matter patterns, and unique connectivity features, displaying lower cognitive performance; SubGroup 3 demonstrated minimal atrophy, superior cognitive performance, and higher physical activity; and SubGroup 1 occupied an intermediate position. This investigation underscores pronounced structural and functional heterogeneity in ABA, revealing three subtypes and paving the way for personalized neuroprotective treatments for age-related neurological, neuropsychiatric, and neurodegenerative diseases.
“…The Lasso (least absolute shrinkage and selection operator) is a regression technique that enhances linear models by penalizing coefficients to prevent overfitting, aiding generalization and variable selection. Its superiority in brain age prediction is welldocumented [34,35]. Hence, we employed the Lasso in our research, with the regularization parameter (alpha) crucial for controlling the penalty magnitude.…”
The intricate dynamics of brain aging, especially the neurodegenerative mechanisms driving accelerated (ABA) and resilient brain aging (RBA), are pivotal in neuroscience. Understanding the temporal dynamics of these phenotypes is crucial for identifying vulnerabilities to cognitive decline and neurodegenerative diseases. Currently, there is a lack of comprehensive understanding of the temporal dynamics and neuroimaging biomarkers linked to ABA and RBA. This study addressed this gap by utilizing a large-scale UK Biobank (UKB) cohort, with the aim to elucidate brain aging heterogeneity and establish the foundation for targeted interventions. Employing Lasso regression on multimodal neuroimaging data, structural MRI (sMRI), diffusion MRI (dMRI), and resting-state functional MRI (rsfMRI), we predicted the brain age and classified individuals into ABA and RBA cohorts. Our findings identified 1949 subjects (6.2%) as representative of the ABA subpopulation and 3203 subjects (10.1%) as representative of the RBA subpopulation. Additionally, the Discriminative Event-Based Model (DEBM) was applied to estimate the sequence of biomarker changes across aging trajectories. Our analysis unveiled distinct central ordering patterns between the ABA and RBA cohorts, with profound implications for understanding cognitive decline and vulnerability to neurodegenerative disorders. Specifically, the ABA cohort exhibited early degeneration in four functional networks and two cognitive domains, with cortical thinning initially observed in the right hemisphere, followed by the temporal lobe. In contrast, the RBA cohort demonstrated initial degeneration in the three functional networks, with cortical thinning predominantly in the left hemisphere and white matter microstructural degeneration occurring at more advanced stages. The detailed aging progression timeline constructed through our DEBM analysis positioned subjects according to their estimated stage of aging, offering a nuanced view of the aging brain’s alterations. This study holds promise for the development of targeted interventions aimed at mitigating age-related cognitive decline.
“…Dinsdale et al [38] applied a deep 3D convolutional neural network architecture based on the T1 MRI images of 19,687 subjects (age range 44.6 to 80.6 years), achieving MAEs of 2.86 years in females and 3.09 years in males, respectively. In a recent study [39], we conducted a comprehensive comparative analysis of six commonly used machine learning models. Our results revealed that the Lasso model demonstrated significantly superior performance compared to the other five models.…”
Age-related cognitive decline is a global phenomenon that affects individuals worldwide. The course and extent of this decline are influenced by numerous factors, such as genetics, lifestyle, education, and cognitive engagement. The theory of brain and cognitive reserve/maintenance posits that these factors have a significant impact on the degree of cognitive decline and overall brain health. However, the absence of standardized definitions and measurements for these terms creates ambiguity in research. To address this issue, we utilized a robust and systematic experimental paradigm, employing a considerably large subject pool comprising 17,030 participants from the UK Biobank. Utilizing advanced machine learning methodologies, we were able to accurately quantify both brain maintenance (BM) and cognitive maintenance (CM), making use of six distinct MRI modalities and nine distinct cognitive capabilities. Our study successfully identified several significant features that were meaningfully associated with both BM and CM outcomes. The results of our study demonstrate that lifestyle factors play a significant role in influencing both BM and CM through unique and independent mechanisms. Specifically, our study found that health status is a critical determinant of BM, while diabetes was found to be moderately associated with CM. Furthermore, our study revealed a positive correlation between BM/CM and cognitive reserve. By carefully considering the unique and independent mechanisms that govern both BM and CM, as well as their correlation with cognitive reserve, our study has provided valuable insight into the various strategies that may be leveraged to promote sustainable interventions to enhance cognitive and brain health across the lifespan.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.